N/A
N=50
Evaluation of the Zynex Blood Volume Monitor in Healthy Adult Patients During a Blood Draw
Blood Loss
Bottom Line
View on ClinicalTrials.gov: NCT01846195 ↗Enrolled (actual)
50
Serious AEs
0.0%
Results posted
Nov 2022
Primary outcome: Primary: Detect by Non-invasive Monitoring a Change in Blood Volume During a Whole Blood Draw — 0; 45 participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- CM 1500 (Device)
- Age
- Adult · 18+ yrs
- Sex
- All
- Sponsor
- Zynex Monitoring Solutions
- Primary completion
- Mar 2013
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Detect by Non-invasive Monitoring a Change in Blood Volume During a Whole Blood Draw |
0; 45 | — |
Summary
Non-invasive monitoring to measure changes in blood volume.
Eligibility Criteria
Inclusion Criteria
- Healthy volunteers
- Between 18-35 years of age
- Weight between 130-200 pounds
Exclusion Criteria
- Known cardiac disease
- Recent caffeine intake
- Tobacco use in the (4) hours prior to screening
- Infection
- Pregnancy
- Hemoglobin <13.5 g/dl
Data sourced from ClinicalTrials.gov (NCT01846195). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.